Prostate saturation biopsy following a first negative biopsy: State of the art - Abstract

Introduction:Saturation prostate biopsy (SPBx) has been initially introduced to improve prostate cancer (PCa) detection rate (DR) in the repeat setting.

Nevertheless, the optimal number and the most appropriate location of the cores, together with the timing to perform a second PBx and the eventual modification of the PBx protocols according to the different clinical situations, are matters of debate. The aim of this review is to perform a critical analysis of the literature about the actual role of SPBx in the repeat setting.

Materials and Methods:We performed a systematic review of the literature since 1995 up to 2011. Electronic searches were limited to the English language, using the MEDLINE database. The key words 'saturation prostate biopsy' and 'repeated prostate biopsy' were used.

Results:SPBx improves PCa DR if clinical suspicion persists after previous biopsy with negative findings and provides an accurate prediction of prostate tumor volume and grade, even if the issue about the number and locations of the cores is still a matter of debate.

Conclusions: At present, SPBx seems to be really necessary in men with persistent suspicion of PCa after negative initial biopsy and probably in patients with a multifocal high-grade prostatic intraepithelial neoplasia or atypical small acinar proliferation. In the remaining situations, adopting an individualized scheme is preferable.

Written by:
Maccagnano C, Gallina A, Roscigno M, Raber M, Capitanio U, SaccĂ  A, Pellucchi F, Suardi N, Abdollah F, Montorsi F, Rigatti P, Scattoni V.   Are you the author?
Department of Urology, San Raffaele Scientific Institute, Milan, Italy.

Reference: Urol Int. 2012 Jul 19. Epub ahead of print.
doi: 10.1159/000339521


PubMed Abstract
PMID: 22814003

UroToday.com Prostate Cancer Section